Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome
Classification Results
AI Classification
PositiveFine-tuned Classification
PositiveAI Classification
PositiveFine-tuned Classification
PositiveCannabis use in Crohn’s disease: a systematic review and meta-analysis of randomized controlled trials (RCTs)
Characterization of the gut phageome of Japanese patients with ulcerative colitis under endoscopic remission
Orally Administered CBD/CBG Hemp Extract Reduces Severity of Ulcerative Colitis and Pain in a Murine Model
Contraception, fertility and inflammatory bowel disease (IBD): a survey of the perspectives of patients, gastroenterologists and women’s healthcare providers
The Intestinal Microbiota: An Environmental Effector for the Endocannabinoid System and Medicinal Cannabis in Inflammatory Bowel Disease
CANNABINOID MEDICINAL CHEMISTRY HAS VAST IMPACT ON PHARMACOLOGY IN MOUSE AND RAT MODELS OF INFLAMMATORY BOWEL DISEASE (IBD)